Clinical Trials · NCT03809000
A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- RTOG Foundation, Inc.
- Enrollment
- 188
- Start date
- Apr 2019
- Locations
- 108 sites, United States, Canada
- Primary endpoint
- Percentage of Participants Alive Without Progression (Progression-Free Survival)